ARTICLE | Clinical News
Lebrikizumab regulatory update
October 22, 2012 7:00 AM UTC
Roche disclosed in its 3Q12 earnings that it will delay submission of regulatory applications for asthma candidate lebrikizumab to after 2016. The pharma said it identified the need to optimize manufa...